Cargando…

Thioredoxin-mimetic peptide CB3 lowers MAPKinase activity in the Zucker rat brain()

Diabetes is a high risk factor for dementia. High glucose may be a risk factor for dementia even among persons without diabetes, and in transgenic animals it has been shown to cause a potentiation of indices that are pre-symptomatic of Alzheimer's disease. To further elucidate the underlying me...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen-Kutner, Moshe, Khomsky, Lena, Trus, Michael, Ben-Yehuda, Hila, Lenhard, James M., Liang, Yin, Martin, Tonya, Atlas, Daphne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3949098/
https://www.ncbi.nlm.nih.gov/pubmed/24624334
http://dx.doi.org/10.1016/j.redox.2013.12.018
_version_ 1782306874007224320
author Cohen-Kutner, Moshe
Khomsky, Lena
Trus, Michael
Ben-Yehuda, Hila
Lenhard, James M.
Liang, Yin
Martin, Tonya
Atlas, Daphne
author_facet Cohen-Kutner, Moshe
Khomsky, Lena
Trus, Michael
Ben-Yehuda, Hila
Lenhard, James M.
Liang, Yin
Martin, Tonya
Atlas, Daphne
author_sort Cohen-Kutner, Moshe
collection PubMed
description Diabetes is a high risk factor for dementia. High glucose may be a risk factor for dementia even among persons without diabetes, and in transgenic animals it has been shown to cause a potentiation of indices that are pre-symptomatic of Alzheimer's disease. To further elucidate the underlying mechanisms linking inflammatory events elicited in the brain during oxidative stress and diabetes, we monitored the activation of mitogen-activated kinsase (MAPKs), c-jun NH(2)-terminal kinase (JNK), p38 MAP kinases (p38(MAPK)), and extracellular activating kinsae1/2 (ERK1/2) and the anti-inflammatory effects of the thioredoxin mimetic (TxM) peptides, Ac-Cys-Pro-Cys-amide (CB3) and Ac-Cys-Gly-Pro-Cys-amide (CB4) in the brain of male leptin-receptor-deficient Zucker diabetic fatty (ZDF) rats and human neuroblastoma SH-SY5Y cells. Daily i.p. injection of CB3 to ZDF rats inhibited the phosphorylation of JNK and p38(MAPK), and prevented the expression of thioredoxin-interacting-protein (TXNIP/TBP-2) in ZDF rat brain. Although plasma glucose/insulin remained high, CB3 also increased the phosphorylation of AMP-ribose activating kinase (AMPK) and inhibited p70(S6K) kinase in the brain. Both CB3 and CB4 reversed apoptosis induced by inhibiting thioredoxin reductase as monitored by decreasing caspase 3 cleavage and PARP dissociation in SH-SY5Y cells. The decrease in JNK and p38(MAPK) activity in the absence of a change in plasma glucose implies a decrease in oxidative or neuroinflammatory stress in the ZDF rat brain. CB3 not only attenuated MAPK phosphorylation and activated AMPK in the brain, but it also diminished apoptotic markers, most likely acting via the MAPK–AMPK–mTOR pathway. These results were correlated with CB3 and CB4 inhibiting inflammation progression and protection from oxidative stress induced apoptosis in human neuronal cells. We suggest that by attenuating neuro-inflammatory processes in the brain Trx1 mimetic peptides could become beneficial for preventing neurological disorders associated with diabetes.
format Online
Article
Text
id pubmed-3949098
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-39490982014-03-12 Thioredoxin-mimetic peptide CB3 lowers MAPKinase activity in the Zucker rat brain() Cohen-Kutner, Moshe Khomsky, Lena Trus, Michael Ben-Yehuda, Hila Lenhard, James M. Liang, Yin Martin, Tonya Atlas, Daphne Redox Biol Research Paper Diabetes is a high risk factor for dementia. High glucose may be a risk factor for dementia even among persons without diabetes, and in transgenic animals it has been shown to cause a potentiation of indices that are pre-symptomatic of Alzheimer's disease. To further elucidate the underlying mechanisms linking inflammatory events elicited in the brain during oxidative stress and diabetes, we monitored the activation of mitogen-activated kinsase (MAPKs), c-jun NH(2)-terminal kinase (JNK), p38 MAP kinases (p38(MAPK)), and extracellular activating kinsae1/2 (ERK1/2) and the anti-inflammatory effects of the thioredoxin mimetic (TxM) peptides, Ac-Cys-Pro-Cys-amide (CB3) and Ac-Cys-Gly-Pro-Cys-amide (CB4) in the brain of male leptin-receptor-deficient Zucker diabetic fatty (ZDF) rats and human neuroblastoma SH-SY5Y cells. Daily i.p. injection of CB3 to ZDF rats inhibited the phosphorylation of JNK and p38(MAPK), and prevented the expression of thioredoxin-interacting-protein (TXNIP/TBP-2) in ZDF rat brain. Although plasma glucose/insulin remained high, CB3 also increased the phosphorylation of AMP-ribose activating kinase (AMPK) and inhibited p70(S6K) kinase in the brain. Both CB3 and CB4 reversed apoptosis induced by inhibiting thioredoxin reductase as monitored by decreasing caspase 3 cleavage and PARP dissociation in SH-SY5Y cells. The decrease in JNK and p38(MAPK) activity in the absence of a change in plasma glucose implies a decrease in oxidative or neuroinflammatory stress in the ZDF rat brain. CB3 not only attenuated MAPK phosphorylation and activated AMPK in the brain, but it also diminished apoptotic markers, most likely acting via the MAPK–AMPK–mTOR pathway. These results were correlated with CB3 and CB4 inhibiting inflammation progression and protection from oxidative stress induced apoptosis in human neuronal cells. We suggest that by attenuating neuro-inflammatory processes in the brain Trx1 mimetic peptides could become beneficial for preventing neurological disorders associated with diabetes. Elsevier 2014-01-09 /pmc/articles/PMC3949098/ /pubmed/24624334 http://dx.doi.org/10.1016/j.redox.2013.12.018 Text en © 2014 The Authors https://creativecommons.org/licenses/by/3.0/This work is licensed under a Creative Commons Attribution 3.0 Unported License (https://creativecommons.org/licenses/by/3.0/) .
spellingShingle Research Paper
Cohen-Kutner, Moshe
Khomsky, Lena
Trus, Michael
Ben-Yehuda, Hila
Lenhard, James M.
Liang, Yin
Martin, Tonya
Atlas, Daphne
Thioredoxin-mimetic peptide CB3 lowers MAPKinase activity in the Zucker rat brain()
title Thioredoxin-mimetic peptide CB3 lowers MAPKinase activity in the Zucker rat brain()
title_full Thioredoxin-mimetic peptide CB3 lowers MAPKinase activity in the Zucker rat brain()
title_fullStr Thioredoxin-mimetic peptide CB3 lowers MAPKinase activity in the Zucker rat brain()
title_full_unstemmed Thioredoxin-mimetic peptide CB3 lowers MAPKinase activity in the Zucker rat brain()
title_short Thioredoxin-mimetic peptide CB3 lowers MAPKinase activity in the Zucker rat brain()
title_sort thioredoxin-mimetic peptide cb3 lowers mapkinase activity in the zucker rat brain()
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3949098/
https://www.ncbi.nlm.nih.gov/pubmed/24624334
http://dx.doi.org/10.1016/j.redox.2013.12.018
work_keys_str_mv AT cohenkutnermoshe thioredoxinmimeticpeptidecb3lowersmapkinaseactivityinthezuckerratbrain
AT khomskylena thioredoxinmimeticpeptidecb3lowersmapkinaseactivityinthezuckerratbrain
AT trusmichael thioredoxinmimeticpeptidecb3lowersmapkinaseactivityinthezuckerratbrain
AT benyehudahila thioredoxinmimeticpeptidecb3lowersmapkinaseactivityinthezuckerratbrain
AT lenhardjamesm thioredoxinmimeticpeptidecb3lowersmapkinaseactivityinthezuckerratbrain
AT liangyin thioredoxinmimeticpeptidecb3lowersmapkinaseactivityinthezuckerratbrain
AT martintonya thioredoxinmimeticpeptidecb3lowersmapkinaseactivityinthezuckerratbrain
AT atlasdaphne thioredoxinmimeticpeptidecb3lowersmapkinaseactivityinthezuckerratbrain